[Trial of device that is not approved or cleared by the U.S. FDA]
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Melissa Guerrero
- Phone Number: 408-560-3339
- Email: melissa@atiavision.com
Study Contact Backup
- Name: Preethi Thiagarajan, OD
- Email: preethi@atiavision.com
Study Locations
-
-
Tamal Nadu
-
Chennai, Tamal Nadu, India, 600018
- Dr Agarwal's Eye Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Visually significant cataract
- Best corrected distance visual acuity between 20/40 and 20/200
- Potential distance visual acuity of 20/32 or better
- Corneal astigmatism ≤ 1.5 diopters
Exclusion Criteria:
- Use of medication that could affect accommodation
- Previous corneal surgery or significant corneal abnormalities
- Ocular pathology or degenerative disorder having potential to impair visual acuity
- Pupil abnormality
- Intraoperative cataract surgery complications that could affect IOL implantation or positioning
Study Plan
How is the study designed?
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: AVL200 IOL
The AVL200 is a modular fluid-filled, shape-changing intraocular lens (IOL) designed to restore visual function across a range of focal points
|
The AVL200 is an intraocular lens surgically implanted in the eye after cataract surgery.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in monocular best corrected distance visual acuity
Time Frame: 3 months postoperative
|
Best-corrected distance visual acuity as measured using an early-treatment diabetic retinopathy study (ETDRS) eye chart
|
3 months postoperative
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in monocular distance-corrected near visual acuity
Time Frame: 3 months postoperative
|
Distance-corrected distance visual acuity as measured using an early-treatment diabetic retinopathy study (ETDRS) eye chart
|
3 months postoperative
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Ashvin Agarwal, MD, Dr. Agarwals Eye Hospital
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion
Primary Completion
Study Completion
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- CP100962
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.